Recommendations for Improved Use of the Murine TNBS-Induced Colitis Model in Evaluating Anti-inflammatory Properties of Lactic Acid Bacteria: Technical and Microbiological Aspects
- 1 February 2006
- journal article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 51 (2), 390-400
- https://doi.org/10.1007/s10620-006-3143-x
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Beneficial effect of auto-aggregatingLactobacillus crispatuson experimentally induced colitis in miceFEMS Immunology & Medical Microbiology, 2005
- Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid BacteriaClinical and Vaccine Immunology, 2003
- IL-10 gene therapy prevents TNBS-induced colitisGene Therapy, 2002
- Probiotics and inflammatory bowel disease: from fads and fantasy to facts and futureBritish Journal of Nutrition, 2002
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002
- Influence of Interleukin-10 on the Interleukin-1 Receptor Antagonist/Interleukin-1β Ratio in the Colonic Mucosa of Ulcerative ColitisDigestion, 2001
- Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tractAlimentary Pharmacology & Therapeutics, 2000
- Probiotic Therapy Fails to Improve Gut Permeability in a Hapten Model of ColitisScandinavian Journal of Gastroenterology, 2000
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Colonic bacteria and bacterial translocation in experimental colitisBritish Journal of Surgery, 1993